MMC vs NEPH · P/E 22, rev $24.46B vs P/E 48, rev $11.2M
Marsh & McLennan Companies Inc (MMC) versus Nephros Inc (NEPH) — a side-by-side from cached financials, not a winner call.
Marsh & McLennan Companies Inc (MMC) is a insurance brokers company listed on US.
Nephros Inc (NEPH) is a medical instruments & supplies company listed on US.
Latest reported MMC revenue for 2024-12-31 was $24.46B. Net income was $4.12B. Revenue was up 7.6% from 2023-12-31 to 2024-12-31. MMC currently screens at market cap $89.82B and trailing P/E 21.9.
Latest reported NEPH revenue for 2026-06-30 was $11.2M. Net income was $1.3M. NEPH currently screens at market cap $40.9M and trailing P/E 48.3.
MMC currently screens at market cap $89.82B and trailing P/E 21.9. NEPH currently screens at market cap $40.9M and trailing P/E 48.3.
Not investment advice. Open the MMC and NEPH stock pages for the full models.
Not investment advice.